The role of nuclear medicine in the diagnosis of Erdheim–chester disease. A series of clinical observations
Erdheim–Chester disease (ECD) is a rare disease with a poor prognosis. The first two cases were reported by Jakob Erdheim and William Chester in 1930. The etiology and disease incidence are unknown. One of the main components of this disorder is a chronic uncontrollable inflammation. In 2016 ECD was...
Main Authors: | , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
ABV-press
2020-04-01
|
Series: | Онкогематология |
Subjects: | |
Online Access: | https://oncohematology.abvpress.ru/ongm/article/view/403 |
_version_ | 1797855534444969984 |
---|---|
author | A. S. Krylov A. D. Ryzhkov A. A. Odzharova Ya. A. Shchipakhina E. E. Stanyakina A. A. Martinovich K. D. Ilkaev A. M. Stroganova S. L. Dranko O. P. Bliznyukovv A. V. Kuzin P. A. Zeynalova A. A. Semenova M. B. Dolgushin |
author_facet | A. S. Krylov A. D. Ryzhkov A. A. Odzharova Ya. A. Shchipakhina E. E. Stanyakina A. A. Martinovich K. D. Ilkaev A. M. Stroganova S. L. Dranko O. P. Bliznyukovv A. V. Kuzin P. A. Zeynalova A. A. Semenova M. B. Dolgushin |
author_sort | A. S. Krylov |
collection | DOAJ |
description | Erdheim–Chester disease (ECD) is a rare disease with a poor prognosis. The first two cases were reported by Jakob Erdheim and William Chester in 1930. The etiology and disease incidence are unknown. One of the main components of this disorder is a chronic uncontrollable inflammation. In 2016 ECD was classified as histiocytic neoplasm by the World Health Organization and was categorized as “tumors of histiocytes and dendritic cells”. More than half of patients testing positive for the BRAF mutation. The final diagnosis is made on the basis of histological finding. There are radiological markers indicating a possible association with the disease. This is a specific, almost pathognomonic scintigraphic picture of the skeleton, “coated” aorta, “hairy” kidney patterns on computer tomography. There is a Erdheim–Chester Disease Global Alliance (ECDGA), which try to unite and provide with information about diagnostics and treatment of this rare disease both patients and doctors. Today, there are 571 registered patients and only one from Russia. We demonstrate three clinical cases of patients with newly diagnosed ECD and the role of nuclear medicine methods in assessing the prevalence of this disease. |
first_indexed | 2024-04-09T20:25:18Z |
format | Article |
id | doaj.art-448b15b5d50f4d92ab5af028bec059eb |
institution | Directory Open Access Journal |
issn | 1818-8346 2413-4023 |
language | Russian |
last_indexed | 2024-04-09T20:25:18Z |
publishDate | 2020-04-01 |
publisher | ABV-press |
record_format | Article |
series | Онкогематология |
spelling | doaj.art-448b15b5d50f4d92ab5af028bec059eb2023-03-30T20:15:12ZrusABV-pressОнкогематология1818-83462413-40232020-04-01151283910.17650/1818-8346-2020-15-1-28-39337The role of nuclear medicine in the diagnosis of Erdheim–chester disease. A series of clinical observationsA. S. Krylov0A. D. Ryzhkov1A. A. Odzharova2Ya. A. Shchipakhina3E. E. Stanyakina4A. A. Martinovich5K. D. Ilkaev6A. M. Stroganova7S. L. Dranko8O. P. Bliznyukovv9A. V. Kuzin10P. A. Zeynalova11A. A. Semenova12M. B. Dolgushin13N. N. Blokhin National Medical Research Center of Oncology, Ministry of Health of RussiaN. N. Blokhin National Medical Research Center of Oncology, Ministry of Health of RussiaN. N. Blokhin National Medical Research Center of Oncology, Ministry of Health of RussiaN. N. Blokhin National Medical Research Center of Oncology, Ministry of Health of RussiaN. N. Blokhin National Medical Research Center of Oncology, Ministry of Health of RussiaN. N. Blokhin National Medical Research Center of Oncology, Ministry of Health of RussiaN. N. Blokhin National Medical Research Center of Oncology, Ministry of Health of RussiaN. N. Blokhin National Medical Research Center of Oncology, Ministry of Health of RussiaN. N. Blokhin National Medical Research Center of Oncology, Ministry of Health of RussiaN. N. Blokhin National Medical Research Center of Oncology, Ministry of Health of RussiaRussian Medical Academy of Continuing Professional Education, Ministry of Health of RussiaN. N. Blokhin National Medical Research Center of Oncology, Ministry of Health of RussiaN. N. Blokhin National Medical Research Center of Oncology, Ministry of Health of RussiaN. N. Blokhin National Medical Research Center of Oncology, Ministry of Health of RussiaErdheim–Chester disease (ECD) is a rare disease with a poor prognosis. The first two cases were reported by Jakob Erdheim and William Chester in 1930. The etiology and disease incidence are unknown. One of the main components of this disorder is a chronic uncontrollable inflammation. In 2016 ECD was classified as histiocytic neoplasm by the World Health Organization and was categorized as “tumors of histiocytes and dendritic cells”. More than half of patients testing positive for the BRAF mutation. The final diagnosis is made on the basis of histological finding. There are radiological markers indicating a possible association with the disease. This is a specific, almost pathognomonic scintigraphic picture of the skeleton, “coated” aorta, “hairy” kidney patterns on computer tomography. There is a Erdheim–Chester Disease Global Alliance (ECDGA), which try to unite and provide with information about diagnostics and treatment of this rare disease both patients and doctors. Today, there are 571 registered patients and only one from Russia. We demonstrate three clinical cases of patients with newly diagnosed ECD and the role of nuclear medicine methods in assessing the prevalence of this disease.https://oncohematology.abvpress.ru/ongm/article/view/403erdheim–chester diseasesingle-photon emission computed tomography combined with computed tomographypositron emission tomography combined with computed tomographyrare clinical case |
spellingShingle | A. S. Krylov A. D. Ryzhkov A. A. Odzharova Ya. A. Shchipakhina E. E. Stanyakina A. A. Martinovich K. D. Ilkaev A. M. Stroganova S. L. Dranko O. P. Bliznyukovv A. V. Kuzin P. A. Zeynalova A. A. Semenova M. B. Dolgushin The role of nuclear medicine in the diagnosis of Erdheim–chester disease. A series of clinical observations Онкогематология erdheim–chester disease single-photon emission computed tomography combined with computed tomography positron emission tomography combined with computed tomography rare clinical case |
title | The role of nuclear medicine in the diagnosis of Erdheim–chester disease. A series of clinical observations |
title_full | The role of nuclear medicine in the diagnosis of Erdheim–chester disease. A series of clinical observations |
title_fullStr | The role of nuclear medicine in the diagnosis of Erdheim–chester disease. A series of clinical observations |
title_full_unstemmed | The role of nuclear medicine in the diagnosis of Erdheim–chester disease. A series of clinical observations |
title_short | The role of nuclear medicine in the diagnosis of Erdheim–chester disease. A series of clinical observations |
title_sort | role of nuclear medicine in the diagnosis of erdheim chester disease a series of clinical observations |
topic | erdheim–chester disease single-photon emission computed tomography combined with computed tomography positron emission tomography combined with computed tomography rare clinical case |
url | https://oncohematology.abvpress.ru/ongm/article/view/403 |
work_keys_str_mv | AT askrylov theroleofnuclearmedicineinthediagnosisoferdheimchesterdiseaseaseriesofclinicalobservations AT adryzhkov theroleofnuclearmedicineinthediagnosisoferdheimchesterdiseaseaseriesofclinicalobservations AT aaodzharova theroleofnuclearmedicineinthediagnosisoferdheimchesterdiseaseaseriesofclinicalobservations AT yaashchipakhina theroleofnuclearmedicineinthediagnosisoferdheimchesterdiseaseaseriesofclinicalobservations AT eestanyakina theroleofnuclearmedicineinthediagnosisoferdheimchesterdiseaseaseriesofclinicalobservations AT aamartinovich theroleofnuclearmedicineinthediagnosisoferdheimchesterdiseaseaseriesofclinicalobservations AT kdilkaev theroleofnuclearmedicineinthediagnosisoferdheimchesterdiseaseaseriesofclinicalobservations AT amstroganova theroleofnuclearmedicineinthediagnosisoferdheimchesterdiseaseaseriesofclinicalobservations AT sldranko theroleofnuclearmedicineinthediagnosisoferdheimchesterdiseaseaseriesofclinicalobservations AT opbliznyukovv theroleofnuclearmedicineinthediagnosisoferdheimchesterdiseaseaseriesofclinicalobservations AT avkuzin theroleofnuclearmedicineinthediagnosisoferdheimchesterdiseaseaseriesofclinicalobservations AT pazeynalova theroleofnuclearmedicineinthediagnosisoferdheimchesterdiseaseaseriesofclinicalobservations AT aasemenova theroleofnuclearmedicineinthediagnosisoferdheimchesterdiseaseaseriesofclinicalobservations AT mbdolgushin theroleofnuclearmedicineinthediagnosisoferdheimchesterdiseaseaseriesofclinicalobservations AT askrylov roleofnuclearmedicineinthediagnosisoferdheimchesterdiseaseaseriesofclinicalobservations AT adryzhkov roleofnuclearmedicineinthediagnosisoferdheimchesterdiseaseaseriesofclinicalobservations AT aaodzharova roleofnuclearmedicineinthediagnosisoferdheimchesterdiseaseaseriesofclinicalobservations AT yaashchipakhina roleofnuclearmedicineinthediagnosisoferdheimchesterdiseaseaseriesofclinicalobservations AT eestanyakina roleofnuclearmedicineinthediagnosisoferdheimchesterdiseaseaseriesofclinicalobservations AT aamartinovich roleofnuclearmedicineinthediagnosisoferdheimchesterdiseaseaseriesofclinicalobservations AT kdilkaev roleofnuclearmedicineinthediagnosisoferdheimchesterdiseaseaseriesofclinicalobservations AT amstroganova roleofnuclearmedicineinthediagnosisoferdheimchesterdiseaseaseriesofclinicalobservations AT sldranko roleofnuclearmedicineinthediagnosisoferdheimchesterdiseaseaseriesofclinicalobservations AT opbliznyukovv roleofnuclearmedicineinthediagnosisoferdheimchesterdiseaseaseriesofclinicalobservations AT avkuzin roleofnuclearmedicineinthediagnosisoferdheimchesterdiseaseaseriesofclinicalobservations AT pazeynalova roleofnuclearmedicineinthediagnosisoferdheimchesterdiseaseaseriesofclinicalobservations AT aasemenova roleofnuclearmedicineinthediagnosisoferdheimchesterdiseaseaseriesofclinicalobservations AT mbdolgushin roleofnuclearmedicineinthediagnosisoferdheimchesterdiseaseaseriesofclinicalobservations |